Oxygenta Pharmaceutical (BOM:524636) PEG Ratio: N/A (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524636 Oxygenta Pharmaceutical Ltd BOM:524636
42 GF Score
Price ₹51.25
GF Value ₹84.23
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Oxygenta Pharmaceutical PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Oxygenta Pharmaceutical's PE Ratio without NRI is 0.00. Oxygenta Pharmaceutical's 5-Year EBITDA growth rate is 0.00%. Therefore, Oxygenta Pharmaceutical's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Oxygenta Pharmaceutical's PEG Ratio or its related term are showing as below:



BOM:524636's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.73
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Oxygenta Pharmaceutical  (BOM:524636) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Oxygenta Pharmaceutical PEG Ratio Related Terms


Oxygenta Pharmaceutical PEG Ratio Historical Data

* Premium members only.

The historical data trend for Oxygenta Pharmaceutical's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxygenta Pharmaceutical PEG Ratio Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oxygenta Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524636 vs ZTS: PEG Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's PEG Ratio falls into.


BOM:524636
42GF Score
Oxygenta Pharmaceutical Ltd BOM:524636
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxygenta Pharmaceutical PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Oxygenta Pharmaceutical's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Oxygenta Pharmaceutical (BOM:524636) Overvalued in 2026?

Based on GuruFocus' analysis, Oxygenta Pharmaceutical stock appears to be undervalued. The current stock price of ₹51.25 is trading 39.2% below its estimated GF Value™ of ₹84.23. GuruFocus considers Oxygenta Pharmaceutical to be Possible Value Trap.

Key valuation signals for BOM:524636:

  • PEG Ratio: N/A
  • GF Value™: ₹84.23 vs. price of ₹51.25 (39.2% below fair value)
  • GF Score™: 42/100 with 5 warning signs

No single metric tells the full story. See the BOM:524636 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxygenta Pharmaceutical Business Description

Address Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad, TG, IND, 500037
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of is engaged in manufacturing and selling of Pharmaceutical, medical, and veterinary preparations. The Company has one reportable segment, which is Pharmaceutical. The group carries out its business operations within India.
42GF Score

Get the complete analysis for BOM:524636

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.25
Price
₹84.23
GF Value